Catalent Inc (CTLT) Stock Price Today
Key Stats
- $11.52BMarket Cap
- -Volume
- HealthSector
- $63.4852W High
- $58.4852W Low
- 32 DaysTypical Hold Time
- $16.13BEnterprise Value
- -Div Yield
- -Trading Activity
Track Catalent Inc (CTLT) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Catalent Inc has traded between a low of $58.48 and a high of $63.48, highlighting its annual price range. Buy and sell Catalent Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Catalent Inc
Catalent is a contract development and manufacturing organization, or CDMO. It operates under four segments: biologics, softgel and oral technologies, oral and specialty delivery, and clinical supply services. Catalent derives its revenues primarily from long-term supply agreements with pharmaceutical customers. The company provides a range of development and manufacturing solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products throughout the entire life cycle of a product from the drug development process to commercial supply. Catalent has over 50 facilities across four continents.
Most Recent News
Ithaca Energy shares rise 3% after $860M Canadian offshore asset acquisition backed by Peel Hunt
Ithaca Energy's shares rose over 3% following Peel Hunt's support for its $860 million acquisition of Canadian offshore oil and gas assets from Suncor. The deal adds significant reserves and production capacity, including interests in Terra Nova and ...
US Treasury yields dip as investors await Fed meeting minutes amid rate hike concerns.
US Treasury yields fell slightly after a recent sharp selloff, with the 10-year yield dropping to 5.255% and the 30-year to 5.614%. The 2-year yield also declined to 4.797%, influenced by a weak jobs report that eased fears of another Federal Reserve...
IG Group shares drop 2.5% after Panmure cuts target price but keeps buy rating
IG Group shares fell 2.5% to 965p after Panmure Liberum lowered its price target from 2,000p to 1,500p following a profit warning. The broker cited a sharp decline in over-the-counter revenue retention, which dropped to around 70% from about 80%, mak...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.